Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study

BACKGROUND: To compare the costs and effects of paliperidone extended release (ER), a new pharmaceutical treatment for the management of schizophrenia, with the most frequently prescribed oral treatments in Greece (namely risperidone, olanzapine, quetiapine, aripiprazole and ziprasidone) over a 1-ye...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Geitona, Maria, Kousoulakou, Hara, Ollandezos, Markos, Athanasakis, Kostas, Papanicolaou, Sotiria, Kyriopoulos, Ioannis
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2008
Matèries:
Primary Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2553072/
https://ncbi.nlm.nih.gov/pubmed/18755025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1744-859X-7-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars